OSR Holdings, Inc. operates as a global healthcare company. The company is headquartered in Bellevue, Washington. The company went IPO on 2023-02-10. Through its subsidiaries, it is engaged in immuno-oncology, regenerative biologics, and medical device technologies. Its operating businesses include developing oral immunotherapies for the treatment of cancer, developing design-augmented (DA) biologics for age-related and other degenerative diseases and neurovascular intervention medical device and systems distribution in Korea. Its subsidiaries include VAXIMM AG (Vaximm); RMC Co., Ltd. (RMC); Darnatein Co., Ltd. (Darnatein), and Woori IO Co., Ltd. (Woori IO). Vaximm is developing oral immunotherapies for the treatment of cancer and immunological disorders. RMC is a Korea-based neurovascular intervention medical device and systems distribution company. Darnatein is developing DA biologics for age-related and other degenerative diseases. Woori IO is a South Korea-based medical device company.
Resultados financieros en millones de dólares estadounidenses. El ejercicio fiscal es febrero - enero.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Ingresos
2
0
0
0
0
0
Crecimiento de los Ingresos (YoY)
--
--
--
--
--
--
Costo de los ingresos
2
--
--
--
--
--
Utilidad bruta
0
--
--
--
--
--
Venta, General y Administración
14
3
1
0
0
0
Investigación y Desarrollo
--
--
--
--
--
--
Gastos de Operación
14
3
1
0
0
0
Otras Ingresos (Gastos) No Operativos
-9
--
--
--
--
--
Ingreso antes de impuestos
-23
-2
0
0
0
0
Gasto por Impuesto a la Renta
-1
0
0
--
--
--
Ingreso Neto
-15
-2
0
0
0
0
Crecimiento de la Utilidad Neta
650%
--
--
--
--
--
Acciones en Circulación (Diluidas)
21.26
4.48
7.71
9.06
7.93
7.93
Cambio de Acciones (YoY)
426%
-42%
-15%
14%
0%
--
EPS (Diluido)
-0.71
-0.53
0.05
0
0
0
Crecimiento de EPS
9%
-1,128%
--
--
--
--
Flujo de efectivo libre
-3
-2
0
0
0
0
Flujo de efectivo libre por acción
--
--
--
--
--
--
Margen bruto
0%
--
--
--
--
--
Margen de operación
-700%
0%
0%
0%
0%
0%
Margen de beneficio
-750%
0%
0%
0%
0%
0%
Margen de flujo de caja libre
-150%
0%
0%
0%
0%
0%
EBITDA
-7
--
--
--
--
--
Margen de EBITDA
-350%
--
--
--
--
--
D&A para EBITDA
7
--
--
--
--
--
EBIT
-14
-3
-1
0
0
0
Margen de EBIT
-700%
0%
0%
0%
0%
0%
Tasa de Impuesto Efectiva
4.34%
0%
0%
--
--
--
Follow-Up Questions
OSR Holdings Inc'in temel mali tabloları nelerdir?
Son mali tabloya (Form-10K) göre, OSR Holdings Inc'in toplam varlıkları $175 olup, net pérdida $-2'dir.
OSRH'ün temel finansal oranları nelerdir?
OSR Holdings Inc'in cari oranı 5.46, net kâr marjı 0, hisse başına satış $0'dir.
OSR Holdings Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?
El segmento de ingresos más grande es OSR Holdings Inc, con unos ingresos de Wealth Management en el último informe de ganancias. En cuanto a la geografía, Switzerland es el mercado principal para OSR Holdings Inc, con unos ingresos de 1,146,900,000.
OSR Holdings Inc kârlı mı?
no, son mali tablolara göre OSR Holdings Inc'in net pérdida $-2'dir.
OSR Holdings Inc'in herhangi bir yükümlülüğü var mı?
sí, OSR Holdings Inc'in yükümlülüğü 32'dir.
OSR Holdings Inc'in tedavüldeki hisse sayısı kaçtır?
OSR Holdings Inc'in toplam tedavüldeki hisse sayısı 2.15'dir.